These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 19249945)

  • 1. Effect of ropinirole on sleep outcomes in patients with restless legs syndrome: meta-analysis of pooled individual patient data from randomized controlled trials.
    Hansen RA; Song L; Moore CG; Gilsenan AW; Kim MM; Calloway MO; Murray MD
    Pharmacotherapy; 2009 Mar; 29(3):255-62. PubMed ID: 19249945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ropinirole in patients with restless legs syndrome and baseline IRLS total scores ≥ 24: efficacy and tolerability in a 26-week, double-blind, parallel-group, placebo-controlled study followed by a 40-week open-label extension.
    Giorgi L; Asgharian A; Hunter B
    Clin Ther; 2013 Sep; 35(9):1321-36. PubMed ID: 23938061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Bogan RK; Fry JM; Schmidt MH; Carson SW; Ritchie SY;
    Mayo Clin Proc; 2006 Jan; 81(1):17-27. PubMed ID: 16438474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries.
    Trenkwalder C; Garcia-Borreguero D; Montagna P; Lainey E; de Weerd AW; Tidswell P; Saletu-Zyhlarz G; Telstad W; Ferini-Strambi L;
    J Neurol Neurosurg Psychiatry; 2004 Jan; 75(1):92-7. PubMed ID: 14707315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study.
    Walters AS; Ondo WG; Dreykluft T; Grunstein R; Lee D; Sethi K;
    Mov Disord; 2004 Dec; 19(12):1414-23. PubMed ID: 15390050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ropinirole treatment for restless legs syndrome.
    Bogan RK
    Expert Opin Pharmacother; 2008 Mar; 9(4):611-23. PubMed ID: 18312162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of ropinirole in patients with restless legs syndrome and a baseline IRLS total score > or = 24 points--data from the ropinirole clinical trial programme.
    Giorgi L; Ritchie SY; Kirsch JM
    Curr Med Res Opin; 2006 Oct; 22(10):1867-77. PubMed ID: 17022844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ropinirole treatment for restless legs syndrome.
    Chitnis S
    Expert Opin Drug Metab Toxicol; 2008 May; 4(5):655-64. PubMed ID: 18484922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ropinirole is effective in the long-term management of restless legs syndrome: a randomized controlled trial.
    Montplaisir J; Karrasch J; Haan J; Volc D
    Mov Disord; 2006 Oct; 21(10):1627-35. PubMed ID: 16874755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ropinirole improves depressive symptoms and restless legs syndrome severity in RLS patients: a multicentre, randomized, placebo-controlled study.
    Benes H; Mattern W; Peglau I; Dreykluft T; Bergmann L; Hansen C; Kohnen R; Banik N; Schoen SW; Hornyak M
    J Neurol; 2011 Jun; 258(6):1046-54. PubMed ID: 21188406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome.
    Allen R; Becker PM; Bogan R; Schmidt M; Kushida CA; Fry JM; Poceta JS; Winslow D
    Sleep; 2004 Aug; 27(5):907-14. PubMed ID: 15453549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
    Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
    Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mixed treatment comparison of gabapentin enacarbil, pramipexole, ropinirole and rotigotine in moderate-to-severe restless legs syndrome.
    Sun Y; van Valkenhoef G; Morel T
    Curr Med Res Opin; 2014 Nov; 30(11):2267-78. PubMed ID: 25050588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Gabapentin Enacarbil on Individual Items of the International Restless Legs Study Group Rating Scale and Post-sleep Questionnaire in Adults with Moderate-to-Severe Primary Restless Legs Syndrome: Pooled Analysis of 3 Randomized Trials.
    Ahmed M; Hays R; Steven Poceta J; Jaros MJ; Kim R; Shang G
    Clin Ther; 2016 Jul; 38(7):1726-1737.e1. PubMed ID: 27288210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted Pressure on Abductor Hallucis and Flexor Hallucis Brevis Muscles to Manage Moderate to Severe Primary Restless Legs Syndrome.
    Kuhn PJ; Olson DJ; Sullivan JP
    J Am Osteopath Assoc; 2016 Jul; 116(7):440-50. PubMed ID: 27367949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychometric evaluation and tests of validity of the Medical Outcomes Study 12-item Sleep Scale (MOS sleep).
    Allen RP; Kosinski M; Hill-Zabala CE; Calloway MO
    Sleep Med; 2009 May; 10(5):531-9. PubMed ID: 18805054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical efficacy of ropinirole for restless legs syndrome is not affected by age at symptom onset.
    Allen RP; Ritchie SY
    Sleep Med; 2008 Dec; 9(8):899-902. PubMed ID: 18024167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the efficacy and tolerability of pramipexole versus ropinirole in the treatment of restless legs syndrome.
    Quilici S; Abrams KR; Nicolas A; Martin M; Petit C; Lleu PL; Finnern HW
    Sleep Med; 2008 Oct; 9(7):715-26. PubMed ID: 18226947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ropinirole treatment for restless legs syndrome.
    Molnar MZ; Fornadi K; Shapiro CM
    Drugs Today (Barc); 2006 Sep; 42(9):587-98. PubMed ID: 17028668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ropinirole: new indication. Restless legs: disproportionate adverse effects.
    Prescrire Int; 2006 Oct; 15(85):173-6. PubMed ID: 17128523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.